Defibrillators Market Growth Steady at 3.1% CAGR to 2022
PUNE, India, February 21, 2018 /PRNewswire/ --
ReportsnReports.com adds Defibrillators Market is forecast to reach $10.88 billion by 2022 from $9.32 billion in 2017 at a CAGR of 3.1% during (2017-2022) driven by technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public access defibrillation and rising number of training & awareness programs across the globe; while the public access markets segment is expected to grow at the fastest CAGR during the forecast period.
Browse 95 Market Data Tables and 28 Figures spread through 169 Pages and in-depth TOC on "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022" http://www.reportsnreports.com/reports/344031-defibrillators-market-by-product-implantable-cardioverter-defibrillator-single-dual-chamber-crt-d-s-icd-and-external-monitor-defibrillator-aed-wearable-by-end-user-hospital-pre-hospital-public-access-home-global-forecast-to-2019.html .
The key players in the defibrillators market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Koninklijke Philips N.V. (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).
The Asia Pacific defibrillators market is expected to grow at the highest CAGR of from 2017 to 2022. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific defibrillators market.
Inquire for DISCOUNT on "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=344031 .
On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The external defibrillators segment is expected to grow at the highest CAGR during 2017 to 2022. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).
The hospitals, clinics, and cardiac centers segment to dominate the Global Defibrillators Market during the forecast period. On the basis of end user, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The hospitals, clinics, and cardiac centers segment is estimated to account for the largest share of the defibrillators market in 2017. Growing number of cardiac implant procedures across the globe and the availability of reimbursements across the developed markets are some of the major factors driving the growth of this segment.
The external defibrillators segment in the global defibrillators market is expected to grow at the highest CAGR in the forecast period, owing to factors such as the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.
Order a copy of "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022" research report at http://www.reportsnreports.com/purchase.aspx?name=344031 .
This report studies the defibrillators market based on product, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
North America is expected to dominate the defibrillators market in 2017. Breakdown of supply-side primary interviews: by company type, designation, and region:
- By Company Type: Tier 1 - 31%, Tier 2 - 48% and Tier 3 - 21%
- By Designation: C-level - 26%, Director level - 24%, Others - 50%
- By Region: North America - 29%, Europe - 35%, APAC - 21%, RoW - 15%
Another research titled Point-of-Care/Rapid Diagnostics Market Global Forecast to 2022 says, the global point-of-care diagnostics market is projected to reach $38.13 billion by 2022 from $23.71 billion in 2017, at a CAGR of 10.0%. The glucose monitoring products segment is expected to command the largest share of the POC diagnostics market in 2017. The molecular diagnostics segment is expected to be the fastest-growing segment during the forecast period. Asia Pacific is expected grow at the highest CAGR during the forecast period. Companies such as Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), Accu BioTech (China), Trinity Biotech (US) have been profiled in this 226 pages research report available at http://www.reportsnreports.com/purchase.aspx?name=1352500 .
Explore more reports on Medical Devices Market at http://www.reportsnreports.com/market-research/medical-devices/ .
About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact:
Hrishikesh Patwardhan
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
Maharashtra, India.
+1-888-391-5441
[email protected]
Connect with Us:
LinkedIn: http://www.linkedin.com/company/reportsnreports
RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml
SOURCE ReportsnReports
Share this article